WHITE PAPER
Cannabis Investing 2026 Update
Focus on the Controllables. An updated read on the U.S. legal cannabis market entering 2026, written for investors and operators who would rather underwrite fundamentals than headlines.
Download the white paper
KEY will use this information to send you the paper and occasional research. This paper is provided for informational and educational purposes only. It is not an offer to sell or a solicitation of an offer to buy any security.
Inside the paper
We set out the policy shifts that reset the ground under the sector, including the move toward Schedule III classification and the closing of the hemp intoxicant loophole, and why they matter for taxation, cash flow, valuations, and capital formation. We then work through what rescheduling changes and what it leaves untouched, and lay out our 2026 and forward outlook across banking normalization, research and healthcare pathways, uplisting dynamics, and the longer arc of federal reform.
The through line is the title. Policy timing is not something an investor or an operator can set. Cost structure, capital discipline, market selection, and underwriting standards are. We describe the metrics we use to separate durable businesses from speculation, and how we apply them across the KEY portfolio.
Who it is for
Allocators, operators, and advisors who follow the sector closely and want a fundamentals-first frame for the next phase of the market.
Written by
The partners of KEY Investment Partners.